Literature DB >> 29788259

Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study.

Hilary A Tindle1,2, Meredith Stevenson Duncan1,3, Robert A Greevy1,2, Ramachandran S Vasan3, Suman Kundu1, Pierre P Massion1,4, Matthew S Freiberg1,2.   

Abstract

Background: The relative risk of lung cancer decreases with years since quitting (YSQ) smoking, but risk beyond 25 YSQ remains unclear. Current lung cancer screening guidelines, which exclude smokers with more than 15 YSQ, may not detect lung cancers in this population.
Methods: We analyzed data from Framingham Heart Study Original (n = 3905) and Offspring cohort (n = 5002) participants for lifetime smoking and lung cancer incidence from 1954 to 1958 (Exam 4) and 1971 to 1975 (Exam 1), respectively, through 2013. We used multivariable-adjusted Cox proportional hazards regression models to compare current, former, and never smokers and lung cancer risk. Smoking status and covariates were time-updated every two years (Original) or four years (Offspring). Primary analyses were restricted to heavy ever smokers with more than 21.3 pack-years; additional analyses included all ever smokers.
Results: On follow-up (median = 28.7 years), 284 lung cancers were detected: incidence rates/1000 person-years in current, former, and never smokers were 1.97 (95% confidence interval [CI] = 1.66 to 2.33), 1.61 (95% CI = 1.34 to 1.93), and 0.26 (95% CI = 0.17 to 0.39), respectively. Heavy former (vs never) smokers had elevated lung cancer risk at all YSQ (<5: hazard ratio [HR] = 12.12, 95% CI = 6.94 to 21.17; 5-9: HR = 11.77, 95% CI = 6.78 to 20.45; 10-14: HR = 7.81, 95% CI = 3.98 to 15.33; 15-24: HR = 5.88, 95% CI = 3.19-10.83; ≥25: HR = 3.85, 95% CI = 1.80 to 8.26). Heavy former (vs current) smokers had 39.1% lower lung cancer risk within five YSQ. Among all former smokers, 40.8% of lung cancers occurred after more than 15 YSQ. Conclusions: Among heavy former smokers, lung cancer risk drops within five YSQ relative to continuing smokers, yet it remains more than threefold higher than never smokers after 25 YSQ. Four of ten lung cancers occurred in former smokers with more 15 YSQ, beyond the screening window of the current guideline.

Entities:  

Mesh:

Year:  2018        PMID: 29788259      PMCID: PMC6235683          DOI: 10.1093/jnci/djy041

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  35 in total

1.  CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations.

Authors:  Catherine A Wassenaar; Yuanqing Ye; Qiuyin Cai; Melinda C Aldrich; Joanne Knight; Margaret R Spitz; Xifeng Wu; William J Blot; Rachel F Tyndale
Journal:  Carcinogenesis       Date:  2014-11-21       Impact factor: 4.944

2.  Lung cancer risk by years since quitting in 30+ pack year smokers.

Authors:  Paul F Pinsky; Claire S Zhu; Barnett S Kramer
Journal:  J Med Screen       Date:  2015-04-29       Impact factor: 2.136

3.  Reduction of risk of dying from tobacco-related diseases after quitting smoking in Italy.

Authors:  Giulia Carreras; Francesco Pistelli; Franco Falcone; Laura Carrozzi; Andrea Martini; Giovanni Viegi; Giuseppe Gorini
Journal:  Tumori       Date:  2015-06-12       Impact factor: 2.098

4.  Modifying risk of developing lung cancer by changing habits of cigarette smoking.

Authors:  J H Lubin; W J Blot; F Berrino; R Flamant; C R Gillis; M Kunze; D Schmähl; G Visco
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-30

5.  Targeting of low-dose CT screening according to the risk of lung-cancer death.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

6.  Cigarette smoking and mortality. MRFIT Research Group.

Authors:  L H Kuller; J K Ockene; E Meilahn; D N Wentworth; K H Svendsen; J D Neaton
Journal:  Prev Med       Date:  1991-09       Impact factor: 4.018

7.  Comparison of aspects of smoking among the four histological types of lung cancer.

Authors:  S A Kenfield; E K Wei; M J Stampfer; B A Rosner; G A Colditz
Journal:  Tob Control       Date:  2008-04-04       Impact factor: 7.552

8.  Cancer mortality among nonsmokers in an insured group of U.S. veterans.

Authors:  E Rogot; J Murray
Journal:  J Natl Cancer Inst       Date:  1980-11       Impact factor: 13.506

9.  Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer.

Authors:  Marileila Varella-Garcia; Lin Chen; Roger L Powell; Fred R Hirsch; Timothy C Kennedy; Robert Keith; York E Miller; John D Mitchell; Wilbur A Franklin
Journal:  Am J Respir Crit Care Med       Date:  2007-06-28       Impact factor: 21.405

10.  That the effects of smoking should be measured in pack-years: misconceptions 4.

Authors:  J Peto
Journal:  Br J Cancer       Date:  2012-07-24       Impact factor: 7.640

View more
  31 in total

1.  Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease.

Authors:  Meredith S Duncan; Matthew S Freiberg; Robert A Greevy; Suman Kundu; Ramachandran S Vasan; Hilary A Tindle
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

Review 2.  Disparities in Lung Cancer Screening: A Review.

Authors:  Diane N Haddad; Kim L Sandler; Louise M Henderson; M Patricia Rivera; Melinda C Aldrich
Journal:  Ann Am Thorac Soc       Date:  2020-04

Review 3.  Low-Dose CT Screening for Lung Cancer: Evidence from 2 Decades of Study.

Authors:  David S Gierada; William C Black; Caroline Chiles; Paul F Pinsky; David F Yankelevitz
Journal:  Radiol Imaging Cancer       Date:  2020-03-27

4.  Reduction in total and major cause-specific mortality from tobacco smoking cessation: a pooled analysis of 16 population-based cohort studies in Asia.

Authors:  Jae Jeong Yang; Danxia Yu; Xiao-Ou Shu; Wanqing Wen; Shafiur Rahman; Sarah Abe; Eiko Saito; Prakash C Gupta; Jiang He; Shoichiro Tsugane; Yu-Tang Gao; Jian-Min Yuan; Woon-Puay Koh; Atsuko Sadakane; Yasutake Tomata; Ichiro Tsuji; Yumi Sugawara; Keitaro Matsuo; Yoon-Ok Ahn; Sue K Park; Yu Chen; Manami Inoue; Daehee Kang; Wei Zheng
Journal:  Int J Epidemiol       Date:  2021-02-05       Impact factor: 7.196

5.  Hybrid models for lung nodule malignancy prediction utilizing convolutional neural network ensembles and clinical data.

Authors:  Rahul Paul; Matthew B Schabath; Robert Gillies; Lawrence O Hall; Dmitry B Goldgof
Journal:  J Med Imaging (Bellingham)       Date:  2020-04-06

6.  A risk-based framework for assessing real-time lung cancer screening eligibility that incorporates life expectancy and past screening findings.

Authors:  Iakovos Toumazis; Oguzhan Alagoz; Ann Leung; Sylvia K Plevritis
Journal:  Cancer       Date:  2021-08-12       Impact factor: 6.860

7.  Responsible biology, aging populations and the 50th anniversary of the "War on Cancer".

Authors:  Colin Farrelly
Journal:  Biogerontology       Date:  2021-06-04       Impact factor: 4.277

8.  Longitudinal analysis of blood markers reveals progressive loss of resilience and predicts human lifespan limit.

Authors:  Timothy V Pyrkov; Konstantin Avchaciov; Andrei E Tarkhov; Leonid I Menshikov; Andrei V Gudkov; Peter O Fedichev
Journal:  Nat Commun       Date:  2021-05-25       Impact factor: 14.919

9.  The impact of smoking on annual healthcare cost: an econometric model analysis in China, 2015.

Authors:  Shiyao Huang; Han Wei; Tingting Yao; Zhengzhong Mao; Qun Sun; Lian Yang
Journal:  BMC Health Serv Res       Date:  2021-02-28       Impact factor: 2.655

10.  Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor.

Authors:  Kari Hemminki; Asta Försti; Akseli Hemminki; Börje Ljungberg; Otto Hemminki
Journal:  BMC Cancer       Date:  2021-05-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.